![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Phesi data show clinical trial suspensions continue to rise as covid-19 impact on development persists
Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back...
Clinical Trials
Q2 Solutions and Tasso Collaborate to Provide Unique Solutions for Patients to Accelerate Adoption of Decentralized Clinical Trials
Q2 Solutions, a wholly-owned subsidiary of IQVIA and a leading clinical trial laboratory services organization, announced a transformative collaboration with Tasso Inc., a pioneer...
Clinical Trials
INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated...
Clinical Trials
Innovation Pharma Completes Enrollment in Phase 2 Clinical Trial for COVID-19
Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, announced that it has achieved full patient enrollment in its randomized, double-blind, placebo-controlled Phase 2 clinical trial...
Clinical Trials
NRx Pharmaceuticals Announces Positive Results for ZYESAMI and Submits EUA Application to US FDA to Treat Critical COVID-19 in Patients
NRx Pharmaceuticals , a clinical stage pharmaceutical company, announced it has filed an application with U.S. FDA requesting Emergency Use Authorization (EUA) for ZYESAMI™...
Clinical Trials
Moderna Reports Positive COVID-19 Vaccine Results in Adolescents
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in...
Clinical Trials
Bharat Biotechs Covaxin approved for phase 2/3 trials on children
The Drugs Controller General of India (DGCI) has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read